Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers
Mika K. Kaneko(Tohoku University), Yukinari Kato(Tohoku University)
Cited by 3
Related Papers
Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors
|Journal of Biological Chemistry|2003|266
A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma
|Oncology Reports|2020|46
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
|Oncotarget|2018|45
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
|Oncology Letters|2020|41
Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models
|International Journal of Molecular Medicine|2023|39